SCHEMBL8292802

SCHEMBL8292802

CCCCS(=O)(=O)NC(=O)CCCCCCCCCCCCCCCCC(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.53
PPARG P37231 7/20 0.53
PPARD Q03181 7/20 0.53
PPARA Q07869 7/20 0.53
HDAC11 Q96DB2 5/20 0.53
TSHR P16473 4/20 0.53
PTPN1 P18031 3/20 0.53
ALDH1A1 P00352 2/20 0.53
TLR2 O60603 2/20 0.53
TDP1 Q9NUW8 2/20 0.53
FABP4 P15090 2/20 0.53
KMT2A Q03164 2/20 0.53
SLC22A6 Q4U2R8 1/20 0.53
SLC22A8 Q8TCC7 1/20 0.53
MEN1 O00255 1/20 0.53
ESR1 P03372 1/20 0.53
ALOX15 P16050 1/20 0.53
PDE4A P27815 1/20 0.53
PDE3A Q14432 1/20 0.53
HSD17B10 Q99714 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8292800 1.00 GPR84 (0.53) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL19049760 0.95 GPR84 (0.57) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL1519481 0.95 GPR84 (0.57) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL91071 0.91 GPR84 (0.50) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL8292801 0.91 HSP90AA1 (0.53) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL19049766 0.89 TSHR (0.48) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL19049767 0.89 TSHR (0.48) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL4732709 0.87 HSP90AA1 (0.53) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL4731984 0.87 HSP90AA1 (0.53) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL4732400 0.87 HSP90AA1 (0.53) GPR84PPARGPPARDPPARAHDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2932981-B1 Albumin-binding derivatives of GLP-1 NOVO NORDISK AS (DK) 2021-06-16 EP disclosed
US-20160108102-A1 Novel GLP-1 Derivatives NOVO NORDISK AS (DK) 2016-04-21 US disclosed
US-20160108102-A1 Novel GLP-1 Derivatives NOVO NORDISK AS (DK) 2016-04-21 US disclosed
EP-2932981-A2 Albumin-binding derivatives of GLP-1 NOVO NORDISK A/S (DK) 2015-10-21 EP disclosed
US-20130244931-A1 Novel GLP-1 Derivatives NOVO NORDISK AS (DK) 2013-09-19 US disclosed
US-20130244931-A1 Novel GLP-1 Derivatives NOVO NORDISK AS (DK) 2013-09-19 US disclosed
US-20130053315-A1 NOVEL GLP-1 DERIVATIVES NOVO NORDISK A/S 2013-02-28 US disclosed
US-20130053315-A1 NOVEL GLP-1 DERIVATIVES NOVO NORDISK A/S 2013-02-28 US disclosed
US-20130040884-A1 ALBUMIN-BINDING CONJUGATES COMPRISING FATTY-ACID AND PEG NOVO NORDISK A/S 2013-02-14 US disclosed
US-20130040884-A1 ALBUMIN-BINDING CONJUGATES COMPRISING FATTY-ACID AND PEG NOVO NORDISK A/S 2013-02-14 US disclosed
US-20100305032-A1 Novel GLP-1 Derivatives NOVO NORDISK A/S (DK) 2010-12-02 US disclosed
US-20100305032-A1 Novel GLP-1 Derivatives NOVO NORDISK A/S (DK) 2010-12-02 US disclosed
US-20070203058-A1 Novel Glp-1 Derivatives NOVO NORDISK A/S (DK) 2007-08-30 US disclosed
US-20070203058-A1 Novel Glp-1 Derivatives NOVO NORDISK A/S (DK) 2007-08-30 US disclosed
WO-2005027978-A2 ALBUMIN-BINDING DERIVATIVES OF THERAPEUTIC PEPTIDES NOVO NORDISK A/S (DK) 2005-03-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130040884-A1 ALBUMIN-BINDING CONJUGATES COMPRISING FATTY-ACID AND PEG FABP1, FABP2, FABP4 GPR84 413/4885PPARG 65/4885PPARD 120/4885
US-20130053315-A1 NOVEL GLP-1 DERIVATIVES GLP1R, GIPR, IAPP GPR84 256/4885PPARG 279/4885PPARD 103/4885
US-20160108102-A1 Novel GLP-1 Derivatives GLP1R, GIPR, IAPP GPR84 256/4885PPARG 279/4885PPARD 103/4885
US-20100305032-A1 Novel GLP-1 Derivatives GLP1R, GIPR, IAPP GPR84 256/4885PPARG 279/4885PPARD 103/4885
US-20070203058-A1 Novel Glp-1 Derivatives GLP1R, GIPR, NPY4R GPR84 461/4885PPARG 1119/4885PPARD 932/4885
US-20130244931-A1 Novel GLP-1 Derivatives GLP1R, GIPR, IAPP GPR84 256/4885PPARG 279/4885PPARD 103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.